Danaher (DHR) Non Operating Investment Income (2013)

Danaher (DHR) posted quarterly Non Operating Investment Income of $229.8 million for Q1 2013.

Danaher (DHR) Non Operating Investment Income (2013) Analysis & Trends

Danaher's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at $229.8 million for Q1 2013.

  • In Q1 2013, Non Operating Investment Income changed N/A year-over-year to $229.8 million; the TTM figure through Dec 2013 stood at $229.8 million (changed N/A YoY), while the FY2013 annual figure was $229.8 million, changed N/A from the prior year.
  • Non Operating Investment Income for Q1 2013 stood at $229.8 million.
  • The five-year high for Non Operating Investment Income was $229.8 million in Q1 2013, with the low at $229.8 million in Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 213.86 Bn 209.80 Bn 8.34 Bn -
2 Danaher 140.41 Bn 136.07 Bn 3.61 Bn -
3 Idexx Laboratories 46.33 Bn 46.13 Bn 779.09 Mn -
4 Agilent Technologies 39.71 Bn 37.90 Bn 990.00 Mn -
5 Iqvia Holdings 39.35 Bn 37.27 Bn 1.44 Bn -
6 Natera 38.97 Bn 37.87 Bn 696.04 Mn -
7 Illumina 30.09 Bn 28.92 Bn 770.00 Mn -
8 Mettler Toledo International 28.70 Bn 28.65 Bn 650.22 Mn -
9 Quest Diagnostics 26.19 Bn 25.56 Bn 1.03 Bn -
10 Labcorp Holdings 25.89 Bn 24.91 Bn 1.01 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2013 229.80 Mn
Mar 29, 2013 229.80 Mn